Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation
- PMID: 21508799
- PMCID: PMC3748592
- DOI: 10.1097/TP.0b013e3182157d44
Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation
Figures
Similar articles
-
Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance.Transplant Proc. 2002 Dec;34(8):3342-4. doi: 10.1016/s0041-1345(02)03696-5. Transplant Proc. 2002. PMID: 12493468 No abstract available.
-
Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.J Immunol. 2003 Dec 15;171(12):6502-9. doi: 10.4049/jimmunol.171.12.6502. J Immunol. 2003. PMID: 14662850
-
Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.J Immunol. 1997 Nov 15;159(10):4665-75. J Immunol. 1997. PMID: 9366389
-
Direct and indirect recognition: the role of MHC antigens in graft rejection.Immunol Today. 1999 Feb;20(2):77-82. doi: 10.1016/s0167-5699(98)01394-2. Immunol Today. 1999. PMID: 10098326 Review.
-
T cell receptor (TCR) repertoire in alloimmune responses.Int Rev Immunol. 1996;13(3):187-207. doi: 10.3109/08830189609061747. Int Rev Immunol. 1996. PMID: 8782741 Review.
Cited by
-
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.J Mol Cell Biol. 2012 Feb;4(1):11-21. doi: 10.1093/jmcb/mjr047. Epub 2011 Dec 14. J Mol Cell Biol. 2012. PMID: 22170955 Free PMC article. Review.
-
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.Front Immunol. 2012 Jul 13;3:184. doi: 10.3389/fimmu.2012.00184. eCollection 2012. Front Immunol. 2012. PMID: 22811678 Free PMC article.
-
Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation.Theranostics. 2020 Jul 1;10(18):8051-8060. doi: 10.7150/thno.43507. eCollection 2020. Theranostics. 2020. PMID: 32724457 Free PMC article.
-
Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction.Immunity. 2017 Dec 19;47(6):1114-1128.e6. doi: 10.1016/j.immuni.2017.11.003. Epub 2017 Dec 5. Immunity. 2017. PMID: 29221730 Free PMC article.
-
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.Front Immunol. 2023 Jun 27;14:1194984. doi: 10.3389/fimmu.2023.1194984. eCollection 2023. Front Immunol. 2023. PMID: 37441063 Free PMC article. Review.
References
-
- Bolton EM, Bradley JA, Pettigrew GJ. Indirect allorecognition: Not simple but effective. Transplantation. 2008;85:667. - PubMed
-
- Gokmen MR, Lombardi G, Lechler RI. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol. 2008;20:568. - PubMed
-
- Grubin CE, Kovats S, deRoos P, et al. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity. 1997;7:197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources